Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

After multivariable-adjustment, analysis of UK two cohorts found no difference in mortality risk with current NSAID use vs non-use in a general population (HR 0.96, 95% CI 0.80 to 1.14) and lower risk in a rheumatoid arthritis/osteoarthritis cohort (0.78, 95% CI 0.64 to 0.94).

Annals of the Rheumatic Diseases